Ethanol extract of Dendrobium chrysotoxum Lindl ameliorates diabetic retinopathy and its mechanism. (Q54351123)

28 May 2018

title

Ethanol extract of Dendrobium chrysotoxum Lindl ameliorates diabetic retinopathy and its mechanism. (English)

1 reference

28 May 2018

1 reference

Dendrobium chrysotoxum

object named as

Dendrobium chrysotoxum

1 reference

Chen-Yuan Gong

1

1 reference

28 May 2018

Zeng-Yang Yu

2

1 reference

28 May 2018

Bin Lu

3

1 reference

28 May 2018

Li Yang

4

1 reference

28 May 2018

Yu-Chen Sheng

5

1 reference

28 May 2018

Yuan-Min Fan

6

1 reference

28 May 2018

Li-Li Ji

7

1 reference

28 May 2018

Zheng-Tao Wang

8

1 reference

28 May 2018

publication date

16 May 2014

1 reference

28 May 2018

published in

Vascular Pharmacology

1 reference

28 May 2018

volume

62

1 reference

28 May 2018

issue

3

1 reference

28 May 2018

page(s)

134-142

1 reference

28 May 2018

Global prevalence and future of diabetes mellitus.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.04.007

Diabetic retinopathy: An update on treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.04.007

Evolving strategies in the management of diabetic retinopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.04.007

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.04.007

A review of clinical trials of anti-VEGF agents for diabetic retinopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.04.007

Anti-angiogenesis drugs in diabetic retinopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.04.007

Review of research on Dendrobium, a prized folk medicine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.04.007

Antioxidant and anti-hyperglycemic activity of polysaccharide isolated from Dendrobium chrysotoxum Lindl

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.04.007

Comparison of hypoglycemic and antioxidative effects of polysaccharides from four different Dendrobium species

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.04.007

Simultaneous determination of phenols (bibenzyl, phenanthrene, and fluorenone) in Dendrobium species by high-performance liquid chromatography with diode array detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.04.007

Current trends in the pharmacotherapy of diabetic retinopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.04.007

Diabetic retinopathy and VEGF.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.04.007

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.04.007

Vascular endothelial growth factor inhibitors (anti-VEGF) in the management of diabetic macular oedema: a systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.04.007

Using the past to inform the future: anti-VEGF therapy as a road map to develop novel therapies for diabetic retinopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.04.007

Critical appraisal of ranibizumab in the treatment of diabetic macular edema

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.04.007

Matrix metalloproteinases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.04.007

Matrix metalloproteinases in diabetic retinopathy: potential role of MMP-9.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.04.007

Role of matrix metalloproteinase-2 and -9 in the development of diabetic retinopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.04.007

Intraocular matrix metalloproteinase 2 and 9 in patients with diabetes mellitus with and without diabetic retinopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.04.007

Angiogenic and antiangiogenic factors in proliferative diabetic retinopathy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.04.007

Angiogenic growth factors and their inhibitors in diabetic retinopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.04.007

NF-kappa B: ten years after

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.04.007

Therapeutic interventions against inflammatory and angiogenic mediators in proliferative diabetic retinopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.04.007

Diabetic retinopathy: current and new treatment options

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2014.04.007

10.1016/J.VPH.2014.04.007

7 January 2021

Identifiers

DOI

1 reference

28 May 2018

release_2au6wmgt7rbw7ob2hdv4fb6upu

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/2au6wmgt7rbw7ob2hdv4fb6upu

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

24846859

1 reference

28 May 2018